Clinical Trials Directory

Trials / Unknown

UnknownNCT04549012

Determination of Blood Loss After CS

Tranexamic Acid Plus Oxytocin Versus Oxtocin Only in Reducing Blood Loss After Cesarean Section

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Comparing betweeen tranexamic acid plus oxytocin and oxytocin alone in their efficacy in reducing blood loss following CS

Detailed description

tranexamic acid plus oxytocin versus oxytocin only in reducing blood loss following CS

Conditions

Interventions

TypeNameDescription
DRUGTranexamic acidcomparison between effect of oxytocin alone and tranexamic acid and oxytocin in reducing blood loss after CS
DRUGOxytocinOxytocin

Timeline

Start date
2020-09-01
Primary completion
2021-09-01
Completion
2021-10-01
First posted
2020-09-16
Last updated
2020-09-16

Source: ClinicalTrials.gov record NCT04549012. Inclusion in this directory is not an endorsement.

Determination of Blood Loss After CS (NCT04549012) · Clinical Trials Directory